At 18th in Beijing State Food and Drug Administration Deputy Director Bian Zhenjia said that this year China's pharmaceutical industry continued to grow steadily, showing robust and growing industry trend overall, according to expert estimates, China is expected to become the world's second largest after the United States pharmaceutical raw materials market.

Bian Zhenjia in the "2011 China-US summit in the pharmaceutical industry," said China has created new drug R & D has achieved fruitful results. Glutathione Since 2008, China launched the "Key New Drug Creation" science and technology major project of this research program, the State Food and Drug Administration approved the drug varieties, nearly two-thirds of China in the world for the first time to determine the chemical structure and role of the target a class of drugs.

He stress that, drug innovation has a large investment, risk, difficult and long life cycle, market wide characteristics, is the patent protection of intellectual property protection, especially dependence on one of the highest technology. Resveratrol Food and drug regulatory authorities for approval of drug registration when the patent issues involved in attention, insisted on approval of drug registration work fully protect the legitimate interests of patent holders.

  He also mention the summit on China-US cooperation. He said he hoped the summit and the future through the Promotion of Chinese medicine and the U.S. Pharmaceutical Research and Manufacturers Association between long-term in-depth exchanges and learning, with mutual respect for each other's national conditions, based on the drugs continue to promote bilateral cooperation in improving intellectual property rights protection system to reach a consensus, Chia seed strengthen cooperation and jointly promote the development of new medicines.
According to statistics, in January 2011 to July, China's pharmaceutical industry realized 802.4 billion yuan output value, an increase of 29.6%.

"Eleventh Five-Year" period, China's major new drug targets exceeded the number of indicators, part of the drug close to the international advanced level. 39 varieties of the existing certificate or to obtain new drug application submitted to hospital, there are 23 drugs to complete all clinical trials, there are nearly 800 varieties of projects in various stages of development. Plant extracts Meanwhile, China has initially established drug innovation system, and a number of important breakthroughs in key technologies in drug discovery, drug synthesis, drug quality control, showed significant progress. Source:www.cospcn.com